Zobrazeno 1 - 10
of 709
pro vyhledávání: '"Steven D. Nathan"'
Autor:
Ho Cheol Kim, MD, Onix Cantres Fonseca, MD, Behnam N. Tehrani, MD, Christopher S. King, MD, Christopher Thomas, MD, Vikramjit Khangoora, MD, Oksana A. Shlobin, MD, Steven D. Nathan, MD
Publikováno v:
JHLT Open, Vol 6, Iss , Pp 100160- (2024)
Background: Right heart catheterization (RHC) is the gold standard for diagnosing pulmonary hypertension (PH) in patients with interstitial lung disease (ILD). However, discrepancies between pulmonary arterial wedge pressure (PAWP) and left ventricul
Externí odkaz:
https://doaj.org/article/42caa08ff3254e10a54a262f69f63733
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 18 (2024)
Background: A six-minute walk test (6MWT) is a reproducible, easily performed test, and is widely used to determine functional exercise capacity in patients with idiopathic pulmonary fibrosis (IPF). However, there is currently a paucity of data on th
Externí odkaz:
https://doaj.org/article/ee4b240bcb0e46a4813372a1f9587f3f
Autor:
Michael B. Keller, MD, Junfeng Sun, PhD, Muhtadi Alnababteh, MD, Lucia Ponor, MD, Pali D. Shah, MD, Joby Mathew, DPT, Hyesik Kong, PhD, Ananth Charya, MD, Helen Luikart, RN, Shambhu Aryal, MD, Steven D. Nathan, MD, Jonathan B. Orens, MD, Kiran K. Khush, MD, Moon Kyoo Jang, PhD, Sean Agbor-Enoh, MD
Publikováno v:
Transplantation Direct, Vol 10, Iss 7, p e1669 (2024)
Background. A prior single-center, retrospective cohort study identified baseline lung allograft dysfunction (BLAD) as a risk factor for death in bilateral lung transplant recipients. In this multicenter prospective cohort study, we test the associat
Externí odkaz:
https://doaj.org/article/7cbc23ee4d4d424099dba7f7eda10cf5
Autor:
Tracey Weiss, Dena R. Ramey, Ngan Pham, Nazneen Fatima Shaikh, Dajun Tian, Xiaohui Zhao, Aimee M. Near, Dominik Lautsch, Steven D. Nathan
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 2, Pp n/a-n/a (2024)
Abstract This retrospective study was conducted to evaluate all‐cause healthcare resource utilization (HCRU) and costs in commercially insured patients living with pulmonary arterial hypertension (PAH) and explore end‐of‐life (EOL)‐related HC
Externí odkaz:
https://doaj.org/article/e1731666b6cb444782d67050c24c44a5
Autor:
Steven D Nathan, Hilary M DuBrock, Victor F Tapson, Aaron B Waxman, Karim El-Kersh, Jason Weatherald, Eric Shen, Chunqin Deng, Steven J Cassady, Rahul G Argula, Franz P Rischard, James Tarver, Deborah J Levine, Manisit Das
Publikováno v:
BMJ Open Respiratory Research, Vol 11, Iss 1 (2024)
Background Inhaled treprostinil (iTre) is the only treatment approved for pulmonary hypertension due to interstitial lung disease (PH-ILD) to improve exercise capacity. This post hoc analysis evaluated clinical worsening and PH-ILD exacerbations from
Externí odkaz:
https://doaj.org/article/32e10c17a26f434b9075064fb45b74c9
Autor:
Tracey Weiss, Aimee M. Near, Xiaohui Zhao, Dena Rosen Ramey, Tania Banerji, Handing Xie, Steven D. Nathan
Publikováno v:
BMC Pulmonary Medicine, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Rationale There is a lack of real-world characterization of healthcare costs and associated cost drivers in patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease (PH-COPD). Objectives To examine (1) excess h
Externí odkaz:
https://doaj.org/article/3ddd0f0dabfb4c3295ffd4fa37824637
Autor:
Steven D. Nathan, Benham Tehrani, Qiong Zhao, Rafael Arias, Dennis Kim, Antonia Pellegrini, Ashley Claire Collins, Jack Diviney, Shourjo Chakravorty, Vikramjit Khangoora, Oksana A. Shlobin, Christopher Thomas, Ben R. Lavon, Christopher S. King, Abhimanyu Chandel
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 1, Pp n/a-n/a (2024)
Abstract Pulmonary vascular dysfunction in the absence of pulmonary hypertension (PH) has been observed in patients with idiopathic pulmonary fibrosis (IPF). We describe the prevalence and etiology of elevated pulmonary vascular resistance (PVR) with
Externí odkaz:
https://doaj.org/article/0736e46afbbf4357b8d2aa58730cdf0c
Autor:
Oksana A. Shlobin, Eric Shen, Stephen J. Wort, Lucilla Piccari, John A. Scandurra, Paul M. Hassoun, Sylvia M. Nikkho, Steven D. Nathan
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 1, Pp n/a-n/a (2024)
Abstract Pulmonary hypertension (PH) due to interstitial lung disease (ILD), a commonly encountered complication of fibrotic ILDs, is associated with significant morbidity and mortality. Until recently, the studies of pulmonary vasodilator therapy in
Externí odkaz:
https://doaj.org/article/9ed23c30ba194e9489b223bcf9cea4b7
Autor:
Paul Ford, Michael Kreuter, Kevin K. Brown, Wim A. Wuyts, Marlies Wijsenbeek, Dominique Israël-Biet, Richard Hubbard, Steven D. Nathan, Hilario Nunes, Bjorn Penninckx, Niyati Prasad, Ineke Seghers, Paolo Spagnolo, Nadia Verbruggen, Nik Hirani, Juergen Behr, Robert J. Kaner, Toby M. Maher
Publikováno v:
ERJ Open Research, Vol 10, Iss 1 (2024)
Background There is no standard definition of respiratory-related hospitalisation, a common end-point in idiopathic pulmonary fibrosis (IPF) clinical trials. As diverse aetiologies and complicating comorbidities can present similarly, external adjudi
Externí odkaz:
https://doaj.org/article/dd10a57961ca4f14aca9968ef542372a